A rectal swab test screening for multidrug-resistant Gram-negative bacteria (MRGN), including carbapenemase-producing organisms, commonly used for infection-control screening around hospital admission or discharge.
1 biomarker as listed by Better2Know.
This test uses a rectal swab to check for colonisation by multidrug-resistant Gram-negative bacteria (MRGN), including carbapenemase-producing organisms. These bacteria resist multiple antibiotics and are of particular concern in hospital and care settings, where screening helps identify carriers before an infection develops or spreads to others.
There is no comparison group recorded for this specific test, but among similarly sized immunity tests we track, its single biomarker places it in the 36th percentile for clinical depth. At £199, it is priced 54% above the £129 median for tests of similar size.
The listing sets out what the swab tests for and how the process works. It scores lower on results and follow-up, since results are not reviewed by a doctor as standard, and turnaround is on the slower side, at up to 5 working days.
This suits people who need to demonstrate they are not carrying multidrug-resistant Gram-negative bacteria, for example before or after a hospital admission, or as part of infection-control screening in a healthcare or care setting.
It is not designed for general symptom investigation. If you have symptoms of an active infection rather than a need for carrier screening, discuss this with a GP rather than relying on this test alone.
A trained professional takes a rectal swab sample at a Better2Know clinic. The swab is sent to the laboratory, where it is cultured and analysed for multidrug-resistant Gram-negative bacteria, including carbapenemase-producing organisms. Results are typically available within 5 working days. The provider does not state that results are reviewed by a doctor as standard.
This rectal swab screens for multidrug-resistant Gram-negative bacteria, including carbapenemase producers, taken at a Better2Know clinic. At £199, it costs 54% more than the £129 median for similarly sized immunity tests we track, and results take up to 5 working days.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
1 biomarkers, placing it in the 36th percentile of immunity tests we track.
A swab sample taken at a clinic; results in around 5 days, slower than similar tests.
Results are not doctor-reviewed and no consultation is included; the provider does not describe the report format.
Trustpilot 4.2 from 775 reviews; CQC registered; trading 18+ years.
£199.00 against a median of £129.00 for the 79 similarly sized immunity tests we track (+54%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
